Many of the cell therapy manufacturing process steps remain largely disconnected and require a human operator to manually transfer cells from step to step
Led by the Georgia Institute of Technology, the NSF Engineering Research Center for Cell Manufacturing Technologies could help revolutionize the treatment of cancer, heart disease, autoimmune diseases, and other disorders
After three patients were blinded following a treatment marketed as a stem cell clinical trial, Stanford ophthalmologist Jeffrey Goldberg calls for increased patient education and regulation
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.